Oxford Tech 4 VCT Portfolio Update : Correction
2021年9月24日 - 3:52PM
RNSを含む英国規制内ニュース (英語)
TIDMOXF
The Board of OT4 VCT notes that Arecor Therapeutics plc
(Arecor), which at 31 May 2021 was 53 % of the OT4 NAV of
30.8p/share was based on an Arecor share price of GBP2.26 which has
now risen to GBP4.30 bid price as at market close on 23 September.
In isolation, each 100p change in Arecor's share price has a 7.15p
impact on the NAV of OT4 VCT.
The Board are in the process of preparing the accounts for the
half year ending 31 August 2021, which will including further
details of the valuation of the rest of the portfolio. These are
expected to be issued in October.
For further information please contact: Lucius Cary 01865
784466
This announcement contains inside information as stipulated
under the UK version of the Market Abuse Regulation No 596/2014
which is part of English Law by virtue of the European (Withdrawal)
Act 2018, as amended. Upon the publication of this announcement via
a Regulatory Information Service, this information is now
considered to be in the public domain.
(END) Dow Jones Newswires
September 24, 2021 02:52 ET (06:52 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Oxford Technology 4 Vent... (LSE:OXF)
過去 株価チャート
から 5 2024 まで 6 2024
Oxford Technology 4 Vent... (LSE:OXF)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Oxford Technology 4 Venture Capital Trust Plc (ロンドン証券取引所): 0 recent articles
その他のOxford Technology 4 Venture Capital Trust Plcニュース記事